PATENT CLAIM ANALYSIS

Application Number: 15759674
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["424", "465000"]

Abstract:
The present invention relates to novel pharmaceutical formulations which have controlled, delayed release of active ingredient, and to a process for the preparation of such formulations. The invention additionally relates to the use of these novel pharmaceutical administration forms as medicaments for the treatment of diseases which require delayed release of the active ingredient, such as hypertension, or asthmatic diseases.

Claim (Index 8):
Process according to  claim 1 , characterised in that the propranolol-containing mixture are compressed with a compression force in the range from 10 to 30 kN to give tablets having hardnesses in the range from 100 to 260 N which have an average release rate of 80% of the active ingredient in a time of at least 9 to 12 hours.

Metadata:
- Claim Count in Document: 52.0
- Percentile: 90.0
- Lexical Diversity: 1.73684
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12224385', '11202713', '14250785', '10630348', '10502648']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7394740814179909
- 35 USC 102 Novelty (BERT): 0.5075479323789294
- Combined Prediction Score: 0.7162814665140846
- Mean Citation Score: 204.225754
- Max Citation Score: 248.98341
- Similarity Product: 162.67302786044775

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test